Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYGlobal Rare Disease Market is estimated to be US$ 547.5 billion by 2030 with a CAGR of 13.1% during the forecast period – by PMIPREV STORYLocus Biosciences completes first-of-its-kind controlled clinical trial for CRISPR-enhanced bacteriophage therapy
